182 related articles for article (PubMed ID: 36635487)
1. Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer Chemoprevention.
Habibi N; Bissonnette C; Pei P; Wang D; Chang A; Raymond JE; Lahann J; Mallery SR
Pharm Res; 2023 Mar; 40(3):749-764. PubMed ID: 36635487
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
Liu L; Yao W; Xie X; Gao J; Lu X
J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
[TBL] [Abstract][Full Text] [Related]
3. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin.
Cheng H; Cui Z; Guo S; Zhang X; Huo Y; Mao S
Acta Biomater; 2021 Nov; 135():506-519. PubMed ID: 34487859
[TBL] [Abstract][Full Text] [Related]
5. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
[TBL] [Abstract][Full Text] [Related]
6. Self-Assembling Monomeric Nucleoside Molecular Nanoparticles Loaded with 5-FU Enhancing Therapeutic Efficacy against Oral Cancer.
Zhao H; Feng H; Liu D; Liu J; Ji N; Chen F; Luo X; Zhou Y; Dan H; Zeng X; Li J; Sun C; Meng J; Ju X; Zhou M; Yang H; Li L; Liang X; Chu L; Jiang L; He Y; Chen Q
ACS Nano; 2015 Oct; 9(10):9638-51. PubMed ID: 26349079
[TBL] [Abstract][Full Text] [Related]
7. Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy.
Gharat SA; Momin M; Bhavsar C
Crit Rev Ther Drug Carrier Syst; 2016; 33(4):363-400. PubMed ID: 27910740
[TBL] [Abstract][Full Text] [Related]
8. ATR-FTIR Characterization of Janus Nanoparticles. Part I: Implementation of Spectroscopic Descriptors.
Kemel K; Tfaili S; Tfayli A; Baillet-Guffroy A; Faivre V; Laugel C
J Pharm Sci; 2018 Sep; 107(9):2457-2464. PubMed ID: 29723538
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulation of dual drug loaded in MLNPs: Implication on sustained drug release and effectively inducing apoptosis in oral carcinoma cells.
Mehnath S; Arjama M; Rajan M; Annamalai G; Jeyaraj M
Biomed Pharmacother; 2018 Aug; 104():661-671. PubMed ID: 29803180
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: Iontophoresis further enhances drug delivery ex vivo.
Matos BN; Pereira MN; Bravo MO; Cunha-Filho M; Saldanha-Araújo F; Gratieri T; Gelfuso GM
Int J Biol Macromol; 2020 Jul; 154():1265-1275. PubMed ID: 31726173
[TBL] [Abstract][Full Text] [Related]
11. In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions.
Lin HY; Thomas JL; Chen HW; Shen CM; Yang WJ; Lee MH
Int J Nanomedicine; 2012; 7():941-51. PubMed ID: 22393291
[TBL] [Abstract][Full Text] [Related]
12. Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
Ma X; Wang H; Jin S; Wu Y; Liang XJ
Int J Nanomedicine; 2012; 7():1313-28. PubMed ID: 22419875
[TBL] [Abstract][Full Text] [Related]
13. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells.
Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P
Colloids Surf B Biointerfaces; 2020 Dec; 196():111279. PubMed ID: 32750605
[TBL] [Abstract][Full Text] [Related]
14. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale investigation of human skin and study of skin penetration of Janus nanoparticles.
Kemel K; Deniset-Besseau A; Baillet-Guffroy A; Faivre V; Dazzi A; Laugel C
Int J Pharm; 2020 Apr; 579():119193. PubMed ID: 32135229
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration.
Abruzzo A; Giordani B; Miti A; Vitali B; Zuccheri G; Cerchiara T; Luppi B; Bigucci F
Int J Pharm; 2021 Sep; 606():120874. PubMed ID: 34252521
[TBL] [Abstract][Full Text] [Related]
17. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas.
Wang X; Li S; Liu H
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemoprevention.
Holpuch AS; Phelps MP; Desai KG; Chen W; Koutras GM; Han BB; Warner BM; Pei P; Seghi GA; Tong M; Border MB; Fields HW; Stoner GD; Larsen PE; Liu Z; Schwendeman SP; Mallery SR
Carcinogenesis; 2012 May; 33(5):1098-105. PubMed ID: 22427354
[TBL] [Abstract][Full Text] [Related]
20. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW
Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
